PAA 7.69% 21.0¢ pharmaust limited

Ann: Phase IIb Dog Trial Achieves Interim Clinical Endpoints, page-91

  1. 451 Posts.
    lightbulb Created with Sketch. 85
    It appears you really do not like other posters putting criticism of PAA on here. Its not @Buckland that has put PAA in a position of criticism it is PAA themselves.
    I hold and will keep doing so but I have moved over the years from a position of being confident they will achieve something to hoping.
    I previously objected to bucklands negative narrative of the BOD but quite frankly only in my opinion it s looking like that is a balanced view. When responses to critical view points are responded to with teenage quips or fly to Norway to ask a question in my view those posters start to lose credibility or are really feeling the pressure of defending their position.

    Overall I am staying the course in the hope that one of their irons in the fire actually heat up.
    Last edited by Banastas: 17/07/21
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
0.015(7.69%)
Mkt cap ! $93.45M
Open High Low Value Volume
20.0¢ 21.5¢ 19.5¢ $459.0K 2.222M

Buyers (Bids)

No. Vol. Price($)
2 103700 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 127225 3
View Market Depth
Last trade - 16.10pm 11/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.